Tags

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The World Health Organization offered a test for Coronavirus early on, and the Trump Administration refused it. Thus, we are in the midst of a massive epidemiological experiment, the scope of which is unknown, as is the final outcome. Coronavirus related experimentation is not only upon non-human primates, but upon human primates, as well.

Early testing would have helped ascertain who to quarantine/how to better manage the coronavirus. Instead, the US coronavirus testing protocol, under Trump, can best be described as don’t seek so you don’t find.

This failure is almost certainly going to serve up many human primate “guinea pigs” for clinical trials. How many will depend on some combination of luck (or not); genetic resistance (or not); and American sense of personal space, which has regional and ethnic variants.

Even in the best case scenario there will be plenty of human primate “guinea pigs” with Coronavirus who will be willing to participate in clinical trials for Gilead Sciences, or anyone else. Gilead has recently called for 400 people: “Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

Jeremiah 46:11:  Go up into Gilead, and take balm… in vain shalt thou use many medicines; for thou shalt not be cured….
Jeremiah 8:22:  Is there no balm in Gilead; is there no physician there? why then is not the health of the daughter of my people recovered?

Members of the President’s Coronavirus Task Force, include former Eli Lilly CEO and biotech lobbyist, Secretary Alex Azar, Department of Health and Human Services and former lobbyist for Gilead, Joseph Grogan, Assistant to the President and Director of the Domestic Policy Council.  https://archive.li/G3f5h

Joseph Grogan Gilead lobbyist: https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=BD790E63-7488-43D0-BE91-CA2403EDC31F&filingTypeID=51

Politico reported: “How testing failures allowed coronavirus to sweep the U.S.: The Trump administration’s decision to forgo a World Health Organization test and create its own had fateful consequences, experts say“. March 6, 2020, Politico: https://archive.li/677Wm


Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
Sponsor:
Gilead Sciences
Information provided by (Responsible Party):
Gilead Sciences
Recruitment Status: Recruiting
First Posted: March 3, 2020 Last Update Posted: March 12, 2020
Interventional  (Clinical Trial)
Estimated Enrollment:
400 participants

Actual Study Start Date:
March 6, 2020
Estimated Primary Completion Date:
May 2020
Estimated Study Completion Date:
May 2020
https://archive.li/2X9Dk

Don’t think for a second that Medicare for All, as written, offers a cure for the bloated medical pharma industrial complex. Rather, glancing through the “Medicare for All” Bills one quickly sees “The Secretary” making critically important decisions, including negotiation of drug prices. That Secretary is apparently the US Secretary of Health and Human Services, who is a constantly changing political appointee-hack appointed by the US President. Thus, if we had “Medicare for All” at the present, as designed by Bernie Sanders and Pramila Jayapal, that all important Secretary would be Alex Azar, former CEO of Eli Lilly & Company and former member of Biotechnology Innovation Organization, a pharmaceutical lobby. See: https://miningawareness.wordpress.com/2020/02/22/the-all-powerful-secretary-in-bernie-sanders-medicare-for-all-bill-is-a-former-big-pharma-drug-ceo-lobbyist-political-hack/

Remember how people/journalists made fun of Trump and said he confused Ebola and CoV-2 (Coronavirus)?
Remdesivir was rapidly pushed through clinical trials due to the West African Ebola virus epidemic of 2013–2016, eventually being used in at least one human patient despite its early development stage at the time. Preliminary results were promising and it was used in the emergency setting during the Kivu Ebola epidemic that started in 2018 along with further clinical trials, until August 2019, when Congolese health officials announced that it was significantly less effective than monoclonal antibodytreatments such as mAb114 and REGN-EB3
In response to the 2019–20 coronavirus outbreak induced by coronavirus SARS-CoV-2, Gilead provided remdesivir for a “small number of patients” in collaboration with Chinese medical authorities for studying its effects…
Also in late January 2020, Chinese medical researchers stated to the media that in exploratory research considering a selection of 30 drug candidates, remdesivir and two other drugs, chloroquine and lopinavir/ritonavir, seemed to have “fairly good inhibitory effects” on SARS-CoV-2 at the cellular level….
https://en.wikipedia.org/wiki/Remdesivir https://archive.li/d97BQ

Coronavirus is actual SARS 2 but they don’t want to scare people so call it other things.

Chloroquine is a much older drug with a long track-record of use, and cheap to make, which the Chinese have found promising: https://en.wikipedia.org/wiki/Chloroquine

Anger grows at Trump administration’s coronavirus testing failures
Donald Trump claimed ‘We have tested heavily’ but in fact just eight tests were carried out on Tuesday, as even allies speak out
https://www.theguardian.com/world/2020/mar/12/coronavirus-us-testing-failures-trump-administration

People should divest from these funds, and invest in something ethical. What good is your retirement fund if you are dead? You can’t take it with you.

From: “Top 10 Owners of Gilead Sciences Inc
The Vanguard Group, Inc.
8.04%
101,623,014
7,048,572,251
+914,299
+0.91%
Capital Research & Management Co….
6.74%
85,132,885
5,904,816,904
+8,343,863
+10.87%
BlackRock Fund Advisors
5.58%
70,527,295
4,891,773,181
+4,670,724
+7.09%
SSgA Funds Management, Inc.
4.60%
58,068,763

See more here; https://archive.li/3nA2d

More details of the clinical trial:
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
Sponsor:
Gilead Sciences
Information provided by (Responsible Party):
Gilead Sciences
Recruitment Status: Recruiting
First Posted: March 3, 2020
Last Update Posted: March 12, 2020
Interventional  (Clinical Trial)
Estimated Enrollment  :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe COVID-19
Actual Study Start Date  :
March 6, 2020
Estimated Primary Completion Date  :
May 2020
Estimated Study Completion Date  :
May 2020
Criteria
Key Inclusion Criteria:
* Willing and able to provide written informed consent prior to performing study procedures
* Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection confirmed by polymerase chain reaction (PCR) test ≤ 4 days before randomization
* Currently hospitalized with fever defined as temperature ≥ 36.6 °C armpit, ≥ 37.2 °C oral, or ≥ 37.8 °C rectal
* Peripheral capillary oxygen saturation (SpO2) ≤ 94% on room air at screening
* Radiographic evidence of pulmonary infiltrates
Key Exclusion Criteria:
* Participation in any other clinical trial of an experimental treatment for COVID-19
* Concurrent treatment with other agents with actual or possible direct acting antiviral activity against SARS-CoV-2 is prohibited 5 X upper limit of normal (ULN)
* Creatinine clearance < 50 mL/min
Note: Other protocol defined Inclusion/Exclusion criteria may apply.

See more here: https://archive.li/2X9Dk

https://en.wikipedia.org/wiki/There_Is_a_Balm_in_Gilead

`Prophet!’ said I, `thing of evil! – prophet still, if bird or devil! –
Whether tempter sent, or whether tempest tossed thee here ashore,
Desolate yet all undaunted, on this desert land enchanted –
On this home by horror haunted – tell me truly, I implore –
Is there – is there balm in Gilead? – tell me – tell me, I implore!’
Quoth the raven, `Nevermore.’
” (Edgar Allen Poe, The Raven)